Epidemic of EHEC (Escherichia coli O104:H4) in Europe in 2011--clinical and therapeutic problems
Simon, K.; Janocha, J.
Przeglad Epidemiologiczny 66(1): 73-77
2012
ISSN/ISBN: 0033-2100 PMID: 22708302 Document Number: 657243
Large outbreak of bloody diarrhoea complicated by haemolytic uraemic sundrome (HUS) has been observed in north Germany since May 2011. Epidemy spreaded throughout Germany and other countries and ceased at the end of July 2011. The WHO and German authorities confirmed that this epidemy was related to infection by new, unusual enteroaggregative Shiga toxin/verotoxin-producing Escherichia coli 014:H4 strain.
Document emailed within 1 workday
Related Documents
Feldsine, P.T.; Green, S.T.; Lienau, A.H.; Kerr, D.E. 2005: Comparative validation study to demonstrate the equivalence of a minor modification to AOAC methods 996.09, Vip for EHEC and 996.10, assurance Eia EHEC with the reference culture method for the detection of Escherichia coli O157:H7 in beef Journal - Association of Official Analytical Chemists 88(4): 1193-1196Farris, A.S.; Wierup, M.; Jacobsson, S.O. 1979: Antibiotic resistance and transferable antibiotica resistance Escherichia coli isolated from calves on a modern farm with therapeutic problems and unsatisfactory management conditions Nordisk Veterinaermedicin 31(1): 20-24
Tseng, C.C. 1981: Studies on pathogenic Escherichia coli. Part 8. Purification and properties of exotoxin from capsular polysaccharide-synthesizing Escherichia coli Journal of the Formosan Medical Association 80(9): 866-872
Moon, H.W.; Rogers, D.G.; Rose, R. 1988: Effects of an orally administered live Escherichia coli pilus vaccine on duration of lacteal immunity to enterotoxigenic Escherichia coli in swine American Journal of Veterinary Research 49(12): 2068-2071
Vernozy-Rozand, C. 1999: Verotoxin-producing Escherichia coli (VTEC) and Escherichia coli O157:H7 in medicine and food industry Annales de Biologie Clinique 57(5): 507-515
Bulte, M. 2004: Occurrence of enterohaemorrhagic E. coli (EHEC) in domestic animals Deutsche Tierärztliche Wochenschrift 111(8): 314-317
Franiek, N.; Orth, D.; Grif, K.; Ewers, C.; Wieler, L.H.; Thalhammer, J.G.; Würzner, R. 2012: ESBL-producing E. coli and EHEC in dogs and cats in the Tyrol as possible source of human infection Berliner und Munchener Tierarztliche Wochenschrift 125(11-12): 469-475
Herlax, V.; Bakas, L.S. 2002: Therapeutic applications of pore-forming lytic toxins: potential use of Escherichia coli alpha-hemolysin Medicina 62(1): 66-72
Uren, J.R.; Ragin, R.C. 1979: Improvement in the therapeutic, immunological, and clearance properties of Escherichia coli and Erwinia carotovora L-asparaginases by attachment of poly-DL-alanyl peptides Cancer Research 39(6 Part 1): 1927-1933
Stepanova, N.F.; Andreeva, I.V.; Kiriushkina, A.A.; Kondrat'ev, I.S.; Likhoded, L.I. 1977: Intergeneric conjugational crossing of Escherichia coli with Salmonella typhimurium. II. Transfer of a polA1 mutation from Escherichia coli to Salmonella typhimurium and its phenotypic expression in the salmonella genome Genetika 13(12): 2189-2194
Xu, J.G.; Qi, G.M. 1996: Clinical and epidemiologic characters and identification of enterohemorrhagic Escherichia coli Zhonghua Liu Xing Bing Xue Za Zhi 17(6): 367-369
Griffin, P.M.; Olmstead, L.C.; Petras, R.E. 1990: Escherichia coli O157:H7-associated colitis. A clinical and histological study of 11 cases Gastroenterology 99(1): 142-149
Schukken, Y.H.; Kremer, W.D.; Lohuis, J.A. 1989: Escherichia coli mastitis in cattle. I. Clinical diagnosis and epidemiological aspects Tijdschrift Voor Diergeneeskunde 114(15-16): 829-838
Bhattacharya, S.K.; Sen, D.; Ganguly, U.; Datta, P.; Saha, M.R.; Datta, D.; Pal, S.C. 1984: Studies on clinical expression of enterotoxigenic Escherichia coli diarrhoea in Calcutta Journal of the Association of Physicians of India 32(12): 1049-1051
Gün, H.; Kocabeyoğlu, O.; Yilmaz, E.; Güngör, S.; Eren, A. 1988: Identification of pathogenic Escherichia coli strains in various clinical material and their antibiotic susceptibility Mikrobiyoloji Bulteni 22(3): 205-214
Kleganov, V.K. 1983: Quantitative microbiological and clinical characteristics of diseases caused by enterotoxigenic Escherichia coli Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2: 31-36
Chlebicki, M.P.; Oh, H.M.L. 2004: Extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella spp. in a Singapore hospital: clinical spectrum Annals of the Academy of Medicine Singapore 33(3): 302-306
Niu, H.; Yee, R.; Cui, P.; Zhang, S.; Tian, L.; Shi, W.; Sullivan, D.; Zhu, B.; Zhang, W.; Zhang, Y. 2020: Identification and Ranking of Clinical Compounds with Activity Against Log-phase Growing Uropathogenic Escherichia coli Current Drug Discovery Technologies 17(2): 191-196
Oethinger, M.; Podglajen, I.; Kern, W.V.; Levy, S.B. 1998: Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli Antimicrobial Agents and Chemotherapy 42(8): 2089-2094
Bradford, P.A.; Jacobus, N.V.; Bhachech, N.; Bush, K. 1996: TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum beta-lactamases Antimicrobial Agents and ChemoTherapy 40(1): 260-262